PapersFlow Research Brief
Mesenchymal stem cell research
Research Guide
What is Mesenchymal stem cell research?
Mesenchymal stem cell research is the scientific investigation of multipotent mesenchymal stem cells derived from adult tissues such as bone marrow, which can differentiate into lineages including bone, cartilage, fat, tendon, muscle, and marrow stroma.
Mesenchymal stem cell research encompasses over 83,678 published works focused on properties like regeneration, immunomodulation, therapeutic interventions, differentiation potential, isolation techniques, transplantation procedures, and cardiac repair. Pittenger et al. (1999) in "Multilineage Potential of Adult Human Mesenchymal Stem Cells" demonstrated that human mesenchymal stem cells from adult marrow replicate as undifferentiated cells and differentiate into multiple mesenchymal tissues. Dominici et al. (2006) in "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement" established standardized criteria for identifying these cells.
Topic Hierarchy
Research Sub-Topics
Mesenchymal Stem Cell Isolation and Characterization
This sub-topic covers techniques for isolating mesenchymal stem cells from various tissues such as bone marrow, adipose, and umbilical cord, along with methods for their phenotypic and functional characterization. Researchers study markers like CD73, CD90, and CD105, as well as multilineage differentiation potential to establish standardized criteria.
Mesenchymal Stem Cell Differentiation Mechanisms
This sub-topic explores the molecular and signaling pathways regulating mesenchymal stem cell differentiation into osteoblasts, chondrocytes, adipocytes, and other lineages. Researchers investigate factors like BMPs, Wnts, and epigenetic modifications influencing lineage commitment.
Immunomodulatory Properties of Mesenchymal Stem Cells
This sub-topic focuses on the mechanisms by which mesenchymal stem cells suppress T-cell proliferation, modulate cytokine secretion, and interact with innate immune cells. Researchers study paracrine factors like IDO, PGE2, and PD-L1 in the context of graft-versus-host disease and autoimmunity.
Mesenchymal Stem Cell Exosome Secretome
This sub-topic examines extracellular vesicles and secreted factors from mesenchymal stem cells, including exosomes containing miRNAs, proteins, and lipids that mediate therapeutic effects. Researchers analyze cargo composition, uptake mechanisms, and applications in cardiac repair and neurodegeneration.
Clinical Translation of Mesenchymal Stem Cell Therapy
This sub-topic addresses challenges in scaling up mesenchymal stem cell manufacturing, safety profiling, and efficacy in phase I-III trials for conditions like osteoarthritis and myocardial infarction. Researchers evaluate engraftment, persistence, and long-term outcomes post-transplantation.
Why It Matters
Mesenchymal stem cell research supports therapeutic applications in tissue regeneration and immunomodulation, with bone marrow-derived cells showing potential in cardiac repair as evidenced by Orlic et al. (2001) in "Bone marrow cells regenerate infarcted myocardium," where bone marrow cells regenerated infarcted heart tissue in animal models. Adipose tissue serves as an alternative source of multipotent stem cells, as Zuk et al. (2001) showed in "Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies" and Zuk et al. (2002) in "Human Adipose Tissue Is a Source of Multipotent Stem Cells," enabling autologous cell-based therapies for mesodermal tissue engineering. These findings underpin clinical trials for conditions like chronic graft-versus-host disease, referenced in Jagasia et al. (2014) with updated NIH criteria incorporating mesenchymal stromal cell potential.
Reading Guide
Where to Start
"Multilineage Potential of Adult Human Mesenchymal Stem Cells" by Pittenger et al. (1999) is the starting point for beginners as it foundational establishes the multipotent differentiation capacity of bone marrow-derived human mesenchymal stem cells with direct experimental evidence.
Key Papers Explained
Pittenger et al. (1999) in "Multilineage Potential of Adult Human Mesenchymal Stem Cells" first characterized bone marrow mesenchymal stem cell multilineage potential into bone, cartilage, fat, and more. Dominici et al. (2006) in "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement" built on this by providing consensus criteria for cell identification, enabling standardized research. Zuk et al. (2001) in "Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies" and Zuk et al. (2002) in "Human Adipose Tissue Is a Source of Multipotent Stem Cells" extended sources to adipose tissue, confirming similar multipotency. Orlic et al. (2001) in "Bone marrow cells regenerate infarcted myocardium" applied these cells to cardiac repair, demonstrating functional regeneration.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research frontiers involve refining isolation techniques and transplantation for immunomodulation and regeneration, as implied by criteria in Dominici et al. (2006) and applications in Orlic et al. (2001). No recent preprints or news indicate ongoing refinements in clinical translation for cardiac repair and graft-versus-host disease.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Multilineage Potential of Adult Human Mesenchymal Stem Cells | 1999 | Science | 20.9K | ✕ |
| 2 | Induction of Pluripotent Stem Cells from Adult Human Fibroblas... | 2007 | Cell | 19.9K | ✕ |
| 3 | Minimal criteria for defining multipotent mesenchymal stromal ... | 2006 | Cytotherapy | 17.3K | ✕ |
| 4 | Embryonic Stem Cell Lines Derived from Human Blastocysts | 1998 | Science | 15.8K | ✕ |
| 5 | The basics of epithelial-mesenchymal transition | 2009 | Journal of Clinical In... | 9.9K | ✓ |
| 6 | Multilineage Cells from Human Adipose Tissue: Implications for... | 2001 | Tissue Engineering | 7.9K | ✕ |
| 7 | Culture of Human Endothelial Cells Derived from Umbilical Vein... | 1973 | Journal of Clinical In... | 6.9K | ✓ |
| 8 | Human Adipose Tissue Is a Source of Multipotent Stem Cells | 2002 | Molecular Biology of t... | 6.6K | ✓ |
| 9 | National Institutes of Health Consensus Development Project on... | 2014 | Biology of Blood and M... | 5.2K | ✓ |
| 10 | Bone marrow cells regenerate infarcted myocardium | 2001 | Nature | 5.2K | ✕ |
Frequently Asked Questions
What are the defining characteristics of multipotent mesenchymal stromal cells?
The International Society for Cellular Therapy defines multipotent mesenchymal stromal cells by minimal criteria including plastic adherence, specific surface antigen expression, and trilineage differentiation into osteoblasts, adipocytes, and chondroblasts. Dominici et al. (2006) in "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement" established these standards for consistent identification across studies. These criteria ensure cells exhibit mesenchymal stem cell properties reliably.
How do mesenchymal stem cells from bone marrow demonstrate multilineage potential?
Human mesenchymal stem cells from adult bone marrow replicate as undifferentiated cells and differentiate into bone, cartilage, fat, tendon, muscle, and marrow stroma. Pittenger et al. (1999) in "Multilineage Potential of Adult Human Mesenchymal Stem Cells" confirmed this multipotency through in vitro and in vivo assays. This potential positions them for regenerative medicine applications.
What sources besides bone marrow provide mesenchymal stem cells?
Human adipose tissue yields multipotent stem cells capable of multilineage differentiation similar to bone marrow mesenchymal stem cells. Zuk et al. (2001) in "Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies" and Zuk et al. (2002) in "Human Adipose Tissue Is a Source of Multipotent Stem Cells" isolated these cells from adipose stroma for cell-based therapies. Adipose-derived cells offer an accessible autologous source.
What role do mesenchymal stem cells play in cardiac repair?
Bone marrow cells, including mesenchymal stem cells, regenerate infarcted myocardium by forming cardiomyocytes and vascular structures. Orlic et al. (2001) in "Bone marrow cells regenerate infarcted myocardium" showed myocardial regeneration post-infarction in mice. This supports their use in cardiac therapeutic interventions.
How are mesenchymal stem cells isolated and cultured?
Mesenchymal stem cells are isolated from bone marrow or adipose tissue stroma and cultured based on plastic adherence and multipotency. Pittenger et al. (1999) detailed isolation from adult human marrow, while Zuk et al. (2002) described adipose-derived methods. Standardized criteria from Dominici et al. (2006) guide consistent culturing.
Open Research Questions
- ? How can mesenchymal stem cell differentiation efficiency into specific lineages like tendon or muscle be enhanced beyond current in vitro methods?
- ? What mechanisms underlie mesenchymal stem cell immunomodulation in suppressing graft-versus-host disease?
- ? Can adipose-derived mesenchymal stem cells achieve equivalent cardiac repair outcomes to bone marrow-derived cells in large animal models?
- ? What long-term engraftment and safety profiles emerge from mesenchymal stem cell transplantation in human clinical trials?
- ? How do epithelial-mesenchymal transitions contribute to myofibroblast generation in fibrosis involving mesenchymal stem cells?
Recent Trends
Mesenchymal stem cell research comprises 83,678 works with established high-citation foundational papers like Pittenger et al. at 20,890 citations defining multilineage potential and Dominici et al. (2006) at 17,309 citations setting identification criteria.
1999No growth rate data, recent preprints, or news coverage available indicates steady maturation without reported accelerations in the last 12 months.
Research Mesenchymal stem cell research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Mesenchymal stem cell research with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers